Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sofianiki Mastronikoli"'
Autor:
Stylianos Mastronikolis, Evangelos Tsiambas, Konstantinos Kagkelaris, Marina Pagkalou, Panagiotis Plotas, Sofianiki Mastronikoli, Dimitrios Roukas, Constantinos D. Georgakopoulos
Publikováno v:
Vision, Vol 6, Iss 4, p 58 (2022)
Fibroblast growth factor (FGF) is a main regulator of cell differentiation, cell migration and angiogenesis in normal and abnormal conjunctiva epithelia, but specific mechanisms of its aberrant expression are yet to be investigated. In the present st
Externí odkaz:
https://doaj.org/article/8686df49972442b1be36425c6eea8cb2
Autor:
GEORGIOS I. METAXAS, DESPOINA SPYROPOULOU, SOFIANIKI MASTRONIKOLI, EVANGELOS TSIAMBAS, EVANGELOS FALIDAS, SPYRIDON MARINOPOULOS, LOUKAS MANAIOS, DIMITRIOS DAVRIS, PANAGIOTIS FOTIADES, DIMITRIOS PESCHOS, CONSTANTINE DIMITRAKAKIS
Publikováno v:
Cancer Diagn Progn
Calpains belong to a family of important calcium-dependent cysteine proteases. They are involved in intracellular processes including cytoskeleton disorganization and substrate proteolysis. They also enhance apoptosis and cell to cell adhesion. Calpa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baafb522e7f7f7a3159429117e4ad066
https://europepmc.org/articles/PMC10165377/
https://europepmc.org/articles/PMC10165377/
Autor:
GEORGIOS I. METAXAS, EVANGELOS TSIAMBAS, SPYRIDON MARINOPOULOS, MARIA ADAMOPOULOU, DESPOINA SPYROPOULOU, EVANGELOS FALIDAS, DIMITRIOS DAVRIS, LOUKAS MANAIOS, PANAGIOTIS FOTIADES, SOFIANIKI MASTRONIKOLI, DIMITRIOS PESCHOS, CONSTANTINE DIMITRAKAKIS
Publikováno v:
Cancer Diagn Progn
DNA mismatch repair system (MMR) is considered a leading genetic mechanism in stabilizing DNA structure and maintaining its function. DNA MMR is a highly conserved system in bacteria, prokaryotic, and eukaryotic cells, and provides the highest protec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ee901acc043a5aa0115bfbbda68a78e
https://europepmc.org/articles/PMC9949550/
https://europepmc.org/articles/PMC9949550/
Autor:
Sofianiki Mastronikoli, Adamantia Zizi-Sermpetzoglou, Eirini Thymara, Evangelos Tsiambas, Paraskevi Tziakou, Nikolaos Kavantzas, Andreas C. Lazaris, Georgia Thomopoulou, Dimitrios Peschos, Grigorios Theodoropoulos
Publikováno v:
Anticancer Research. 41:3809-3813
Background/aim Renal cell carcinoma (RCC) comprises a variety of pathological entities. Many RCCs are aggressive, demanding efficient targeted and immunetherapeutic strategies. Programmed cell death ligand-1 (PD-L1) is expressed mainly in hematopoiet
Autor:
EVANGELOS FALIDAS, EIRINI KITSIOULI, DESPOINA SPYROPOULOU, EVANGELOS TSIAMBAS, ASIMINA KALOGIROU, GEORGE TSOUVELAS, STYLIANOS PAPADOPOULOS, MICHAIL MITSIS, MARILENA LEKKA, SOFIANIKI MASTRONIKOLI, DIMITRIOS PESCHOS, ODYSSEAS DIMAS, KONSTANTINOS VLACHOS
Publikováno v:
In Vivo
Background/Aim: Phospholipases A2 represent a family of enzymes that regulate the metabolism of phospholipids by hydrolyzing them into fatty acids. Secretory phospholipase A2 (SPLA2) catalyzes the calcium-dependent 2-acyl groups hydrolysis to produce
Autor:
Vasileios, Ragos, Aristeidis, Chrysovergis, Sofianiki, Mastronikoli, Chrissa, Sioka, Asimakis, Asimakopoulos, Evangelos, Giotakis, Evangelos, Tsiambas, Athanasios, Niotis, Panagiotis, Fotiades, Efthymios, Kyrodimos, Nicholas, Mastronikolis
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 26(3)
To describe a new technique of surgical treatment of the lip commissure or buccal mucosa carcinomas, where we use local flaps (skin, buccal mucosa) of the sliding type.According to the current technique, the ectomy ranges horizontally and in a cuneif
Autor:
Nicholas, Mastronikolis, Evangelos, Tsiambas, Dimitrios, Roukas, Panagiotis, Fotiades, Aristeidis, Chrysovergis, Vasileios, Papanikolaou, Efthymios, Kyrodimos, Sofianiki, Mastronikoli, Athanasios, Niotis, Vasileios, Ragos
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 25(5)
Among biomarkers that should be useful for a molecular discrimination of patients regarding treatment strategies and prognosis in solid malignancies, novel micro-RNAs (miRs) are under investigation. Quite recently, miRs are considered very promising